Rxo (RXO) Return on Equity (2022 - 2026)

Rxo (RXO) has reported Return on Equity for 5 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.

• Return on Equity for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Equity was 0.0% for Q1 2026 at Rxo, down from 0.0% in the prior quarter.
• Over five years, Return on Equity peaked at 0.0% in Q2 2022 and troughed at 0.0% in Q3 2024.
• Average Return on Equity over 5 years is 0.0%, with a median of 0.0% recorded in 2024.
• The widest YoY moves for Return on Equity: up 0 bps in 2023, down 0 bps in 2023.
• Over 5 years, Return on Equity stood at 0.0% in 2022, then plunged by 94 bps to 0.0% in 2023, then tumbled by 2730 bps to 0.0% in 2024, then soared by 64 bps to 0.0% in 2025, then declined by 7 bps to 0.0% in 2026.
• Per Business Quant data, the three most recent Return on Equity figures were 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.